Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results

Provided By GlobeNewswire

Last update: May 13, 2024

- Oral presentation at ASGCT described selective, high levels of therapeutic transgene delivery to T cells in vivo by cell-targeted lipid nanoparticle (ctLNP)